Alembic Pharmaceuticals Gains US FDA Nod for Acitretin Capsules
Alembic Pharmaceuticals Limited has secured final approval from the US FDA for its Acitretin Capsules USP in doses of 10 mg, 17.5 mg, and 25 mg. These capsules are therapeutically equivalent to Soriatane Capsules by Stiefel Laboratories and are indicated for treating severe psoriasis in adults. The market size for Acitretin Capsules is estimated at $21 million.
- #general surgery
- #pharmacology
- #general medicine
- #psych
- #rheumatology
- #pathology
- #radiology
- #anaesthesia
- #psychiatry
- #fmt
- #emergency medicine
- #academics
- #nursing
- #pharmacy
- #trichology
- #andrology
- #orthopaedics
- #critical care
- #dermatology
- #dentistry
- #oncology
- #business
- #gastroenterology
- #nephrology
- #diagnostics
- #urology
- #ophthalmology
- #gynaecology - ivf
- #pediatrics
- #neurology
- #ent
- #pulmonology
- #family health
- #cardiology
- #endo-diabetology